Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Cephalon awarded patents for IGF-1

Aug. 26, 1997

FDA approves Watson's estazolam

Aug. 25, 1997

Amgen acquires rights to FKBP-neuroimmunophilin ligands

Aug. 25, 1997

New nonpeptide substance P antagonist from Pfizer

Aug. 25, 1997

New D4 antagonist may aid in the search for antipsychotic drugs

Aug. 25, 1997

Titan's Spheramine receives orphan drug designation

Aug. 25, 1997

FDA approves hand implant for quadriplegics

Aug. 22, 1997

Substance P antagonists discovered at Kotobuki

Aug. 21, 1997

Nonpeptide CRF1 antagonist reduces cerebral infarction in rats

Aug. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...